Progyny, Inc. (PGNY) stock analysis

PGNY · Progyny, Inc.

Latest recorded price: USD 37.15

Model-estimated fair value: USD 27.84. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Healthcare Plans

At $37.15, PGNY trades 33.4% above the model's base-case value of $27.84. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $21.64 in the conservative case and $35.31 in the optimistic case, with a valuation confidence score of 93/100. Fiscal 2025 figures: revenue growth 17.9%, free cash flow margin 14.9%, ROIC 21.0%. The model does not flag any risk signals for this company.

Similar companies in Healthcare